Heterozygous mice with a targeted deletion of Gabrg2 (Gabrg2+/-) have absence seizures but no spontaneous generalised tonic-clonic seizures (GTCS). The gene discussed is GABRG2; the disease is Bilateral tonic-clonic seizure.